drugset / Trial / NCT07320781

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

NCT07320781

RandomizedParallel-groupDouble-blindPrevention

Summary

This study evaluated the preemptive analgesic efficacy of Tapentadol in reducing peri operative analgesic requirements among patients undergoing breast cancer surgery.

Timeline

Start
2024-11-15
Primary completion
2025-09-30
Completion
2025-10-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tapentadol Small molecule 75 mg Oral

Indications